Table 2.
Variables | Placebo Group (n = 18) |
OMEGA Group (n = 18) |
Main Effects and Interactions (p Value) |
||
---|---|---|---|---|---|
Time | Time X Group | Group | |||
Left Single Support (s) | |||||
Baseline | 0.436 ± 0.04 | 0.440 ± 0.04 | 0.896 | 0.035 | 0.328 |
12 months | 0.443 ± 0.03 | 0.437 ± 0.04 | |||
24 months | 0.452 ± 0.04 | 0.421 ± 0.03 | |||
Right Step Time (s) | |||||
Baseline | 0.577 ± 0.06 | 0.555 ± 0.05 | 0.047 | 0.025 | 0.131 |
12 months | 0.586 ± 0.06 | 0.579 ± 0.08 | |||
24 months | 0.589 ± 0.08 | 0.526 ± 0.05 | |||
Left Stride Time (s) | |||||
Baseline | 1.16 ± 0.14 | 1.12 ± 0.09 | 0.148 | 0.051 | 0.073 |
12 months | 1.17 ± 0.1 | 1.14 ± 0.16 | |||
24 months | 1.18 ± 0.15 | 1.05 ± 0.12 | |||
Right Stride Time (s) | |||||
Baseline | 1.15 ± 0.14 | 1.11 ± 0.09 | 0.196 | 0.039 | 0.060 |
12 months | 1.16 ± 0.1 | 1.13 ± 0.13 | |||
24 months | 1.17 ± 0.16 | 1.04 ± 0.11 |
Data expressed as mean ± SD. Bold text indicates a statistically significant difference with a p-value less than 0.05.